Tricuspid Valve Dysfunction Following Pacemaker or Cardioverter-Defibrillator Implantation

Abstract The potential for cardiac implantable electronic device leads to interfere with tricuspid valve (TV) function has gained increasing recognition as having hemodynamic and clinical consequences associated with incremental morbidity and death. The diagnosis and treatment of lead-related (as di...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology Vol. 69; no. 18; pp. 2331 - 2341
Main Authors: Chang, James D., MD, Manning, Warren J., MD, Ebrille, Elisa, MD, Zimetbaum, Peter J., MD
Format: Journal Article
Language:English
Published: United States Elsevier Inc 09-05-2017
Elsevier Limited
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract The potential for cardiac implantable electronic device leads to interfere with tricuspid valve (TV) function has gained increasing recognition as having hemodynamic and clinical consequences associated with incremental morbidity and death. The diagnosis and treatment of lead-related (as distinct from functional) tricuspid regurgitation pose unique challenges. Because of pitfalls in routine diagnostic imaging, a high level of clinical suspicion must be maintained to avoid overlooking the possibility that worsening heart failure is a consequence of mechanical interference with TV leaflet mobility or coaptation and is amenable to lead extraction or valve repair or replacement. The future of cardiac implantable electronic devices includes pacing and perhaps defibrillation without a lead traversing the TV.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2017.02.055